Jorey Chernett
CIK 2042077 · last filed 2026-10-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
STIM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BLOOMFIELD HILLS, MI 48301
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XGN | 10%+ Owner | 2,618,540 | $7.47 | $19.56M | $104.4K | 1 | 2026-10-20 |
| Oncology Institute, Inc. (TOI) Delisted | 10%+ Owner | 10,660,858 | $5.13 | $54.69M | $351.4K | 4 | 2026-08-17 |
| STIM | 10%+ Owner | 10,602,988 | $2.24 | $23.75M | $4.81M | 11 | 2026-08-17 |
| Oncology Institute, Inc. (TOIIW) Delisted | 10%+ Owner | 10,579,858 | $0.05 | $518.4K | $2.33M | 9 | 2026-06-05 |
| AIRS | 10%+ Owner | 7,053,761 | $1.17 | $8.25M | $1.99M | 12 | 2026-04-20 |
Recent Filings · Page 2 of 4
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-20 | Oncology Institute, Inc. (TOIIW) Delisted | Buy (P) | +30,000 | $122.7K | EDGAR |
| 2026-05-13 | STIM | Buy (P) | +475,000 | $636.5K | EDGAR |
| 2026-04-22 | STIM | Buy (P) | +200,000 | $309.0K | EDGAR |
| 2026-04-20 | AIRS | Mixed | +40,000 | $101.6K | EDGAR |
| 2026-04-15 | AIRS | Buy (P) | +20,000 | $52.0K | EDGAR |
| 2026-04-13 | Oncology Institute, Inc. (TOIIW) Delisted | Buy (P) | +20,000 | $62.0K | EDGAR |
| 2026-04-08 | AIRS | Buy (P) | +60,000 | $175.8K | EDGAR |
| 2026-04-06 | AIRS | Buy (P) | +90,000 | $253.8K | EDGAR |
| 2026-03-30 | STIM | Buy (P) | +385,442 | $481.8K | EDGAR |
| 2026-03-30 | STIM | Buy (P) | +500,000 | $675.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.